plagiochiline A

Plagiochiline A is a 2,3-secoaromadendrane-type sesquiterpenoid natural product isolated from the Peruvian medicinal plant *Plagiochila distichia* and other species of the *Plagiochila* genus. It has demonstrated potent antiproliferative and cytotoxic activity against a broad spectrum of solid tumor cell lines, including prostate (DU145), colon, breast, lung, and cervical cancers, as well as various leukemia cell lines. Mechanistic studies suggest that plagiochiline A acts by inhibiting cytokinesis, the final stage of cell division. Treatment with the compound leads to a significant accumulation of cells in the G2/M phase of the cell cycle and the formation of binucleate cells characterized by persistent intercellular bridges, indicating a failure in the completion of cytoplasmic division. It is currently being investigated as a lead compound for the development of novel antineoplastic agents that specifically target the cytokinesis process.

Other names

plagiochiline A